1. Primarily affected cognitive domains

Cognitive impairment in menopausal women is concentrated in three core areas:

Memory function: verbal memory and working memory are the most obviously impaired, especially in the first year after menopause, which is reflected in short-term memory decline and information retrieval difficulties, and differences can be detected by objective assessments such as the Rey Auditory Verbal Learning Test (RAVLT) and the logical memory test. while unconscious memory such as procedural memory (such as cycling, cooking, and other skills memory) is relatively stable.

Attention and executive function: persistent inattention, slowed down information processing, abnormalities can be found in tests such as number symbol test (PASAT) and reverse counting; In terms of executive function, planning ability, cognitive flexibility and inhibitory control are weakened, which is manifested as difficulty in multitasking and reduced decision-making efficiency.

Social cognition and emotional regulation: 43% of perimenopausal women will experience subclinical symptoms such as anxiety, emotional instability, and irritability, which interact with cognitive decline and further aggravate distraction and memory loss.

2. Core mechanism: the chain reaction of estrogen decline

As a "protective factor" in the brain, estrogen's receptors are widely distributed in key cognitive brain regions such as the prefrontal cortex, hippocampus, and amygdala, and can play a neuroprotective role by regulating synaptic plasticity, neurotransmitter pathways, brain metabolism and anti-inflammatory responses. Dropped estrogen levels during menopause can trigger a chain reaction:

Synaptic plasticity decreases and neuronal connectivity function is weakened;

Abnormal brain glucose metabolism leads to maladaptive transformation of ketone body metabolism, resulting in a decrease in brain function activity;

Neuroinflammation is activated, the release of pro-inflammatory factors increases, and oxidative stress and neuronal damage are exacerbated.

amyloid clearance decreases, increasing the risk of cognitive decline.

In addition, early-onset menopause (< 40 years old) significantly increases the risk of future dementia, which is comparable to traditional vascular risk factors such as smoking and stroke.

Menopause hormone therapy (MHT) is an important means of cognitive protection, but the core is "precise timing", which requires strict adherence to evidence-based conclusions in the literature:

1. Applicable people and timing

Priority is given to women in early menopause (50-62 years old), and starting MHT at this stage can exert a neuroprotective effect, reduce the risk of Alzheimer's disease, and especially improve speech memory;

Estrogen alone therapy in surgically menopausal women can significantly improve digital breadth test performance, with moderate to significant benefits on cognitive function;

MHT in women over 65 years of age has no cognitive protective effect and may increase the risk of dementia, so it is not recommended.

2. Medication specifications

Recommended preparation: 17β-estradiol is preferred, and the neuroprotective effect is clear;

Medication principles: individualized assessment of contraindications (such as breast cancer, history of thrombosis), use the lowest effective dose, and short-term use to balance benefits and risks;

Limitations: Meta-analyses showed that MHT in naturally postmenopausal women had no significant effect on overall cognition in middle age, and only surgical menopausal women achieved clear cognitive improvement.

Dietary interventions protect cognition by regulating brain metabolism and reducing neuroinflammation, and all recommendations are based on evidence-based protocols recommended in the literature:

Mediterranean diet: can delay age-related cognitive decline and reduce the risk of brain atrophy;

MIND diet: focuses on 10 types of brain-strengthening foods (green leafy vegetables, berries, nuts, olive oil, fish, poultry, beans, whole grains, wine), and avoids 5 types of unhealthy foods (red meat and products, butter/margarine, cheese, desserts, fast food), which has a clear protective effect on overall cognitive function;

Adjuvant regimen: Intermittent fasting and ketogenic diet can improve brain metabolism and have potential benefits for cognitive protection, which need to be adjusted according to individual health conditions.

2. Key nutrients

Polyunsaturated fatty acids (Omega-3/6): have anti-inflammatory and antioxidant effects, and help maintain nerve cell function;

Phytoestrogens (isoflavones): may mimic the effects of estrogen and reduce neuroinflammation and neurodegeneration, with low-quality evidence supporting its role in reducing the risk of Alzheimer's disease;

Others: Dietary fiber, B vitamins, and antioxidants (such as vitamins C and E) can protect cognition by improving metabolism and reducing oxidative stress.

Exercise protects cognition by increasing cerebral blood flow and promoting synaptic plasticity, and needs to follow the synergistic principle of "aerobic + strength", and the specific plan is strictly based on literature data:

Aerobic exercise: 150 minutes of moderate-intensity or 75 minutes of high-intensity aerobic exercise per week can increase hippocampal volume and improve memory and executive function;

Strength training: muscle strengthening training at least 2 times a week, synergized with aerobic exercise, can significantly improve concentration and information processing speed;

Featured exercises: Pilates can improve sleep quality, reduce anxiety, and indirectly alleviate cognitive deterioration; Kundalini yoga can reverse aging-related biomarkers and protect neural pathways; Dual-task training (simultaneous exercise and cognitive tasks) can simultaneously improve cognitive function and physical fitness.

2. Implementation points

Intensity control: step by step to avoid excessive fatigue, postmenopausal women can be combined with balance training to reduce the risk of falls and indirectly protect cognitive-related brain areas;

Adhere to the principle: long-term regular exercise can be effective, it is recommended to fix the exercise period and cultivate continuous habits.

In addition to hormones, diet, and exercise, managing the following risk factors is crucial for cognitive protection and is a key point highlighted in the literature:

2. Improve lifestyle: quit smoking and limit alcohol, ensure adequate sleep for 7-8 hours a day, and avoid sitting for a long time;

3. Strengthen cognitive stimulation: Engaging in mental activities such as reading, puzzles, and learning new skills can increase the volume of gray matter in the brain and reduce the risk of amyloid deposition.

4. Regular cognitive screening: Cognitive status was monitored using tools such as the Montreal Cognitive Assessment (MoCA) and the Menopause Rating Scale (MRS), and the total MRS score of >16 suggested that severe symptoms required intervention (sensitivity 60%-84.6%, specificity 63.7%-99.4%).

Cognitive changes during menopause are the result of the combined effects of hormone fluctuations, aging and lifestyle, and are not "inevitable slippery slopes". Through core interventions such as hormone therapy (grasping the early window), scientific diet (following the Mediterranean/MIND model), regular exercise (aerobic + strength synergy), coupled with the management of underlying diseases and supplementation with cognitive stimulation, a comprehensive cognitive protection system can be formed. These strategies are based on evidence-based evidence from authoritative reviews without data embellishment or exaggeration, providing accurate and safe cognitive guardianship programs for menopausal women to help women smoothly navigate this transition period and maintain brain health and quality of life.